# Central Sensitization as a Marker of Cognitive and Emotional Vulnerability in Chronic Low Back Pain

**Authors:** Anna Anselmo, Irene Cappadona, Maria Pagano, Alice Laudisio, Rosaria De Luca, Fabrizio Russo, Giulia Martello, Davide Cardile, Angelo Quartarone, Rocco Salvatore Calabrò, Francesco Corallo

PMC · DOI: 10.3390/brainsci16030290 · Brain Sciences · 2026-03-05

## TL;DR

Chronic low back pain patients with central sensitization show worse cognitive and emotional outcomes, suggesting a distinct subgroup needing targeted care.

## Contribution

Identifies central sensitization as a marker for cognitive and emotional vulnerability in chronic low back pain patients.

## Key findings

- Central sensitization is linked to higher pain catastrophizing, depressive symptoms, and lower cognitive performance.
- Patients with central sensitization form a distinct clinical subgroup beyond pain intensity.
- The Central Sensitization Inventory can help identify patients at risk for cognitive and emotional dysfunction.

## Abstract

What are the main findings?
Central sensitization in chronic low back pain is associated with worse cognitive performance, higher depressive symptoms, and increased pain catastrophizing across all domains.Patients with central sensitization represent a distinct clinical subgroup characterized by a multidimensional vulnerability profile extending beyond pain intensity.

Central sensitization in chronic low back pain is associated with worse cognitive performance, higher depressive symptoms, and increased pain catastrophizing across all domains.

Patients with central sensitization represent a distinct clinical subgroup characterized by a multidimensional vulnerability profile extending beyond pain intensity.

What are the implications of the main findings?
The Central Sensitization Inventory may be a valuable tool for early identification and clinical stratification of patients at risk for cognitive and emotional dysfunction.Integrating central sensitization assessment into routine practice could support personalized, multimodal interventions targeting cognitive, emotional, and behavioral processes.

The Central Sensitization Inventory may be a valuable tool for early identification and clinical stratification of patients at risk for cognitive and emotional dysfunction.

Integrating central sensitization assessment into routine practice could support personalized, multimodal interventions targeting cognitive, emotional, and behavioral processes.

Background and Aim: Low back pain (LBP) represents an important public health issue, with approximately 20% of acute cases progressing to chronic low back pain (CLBP). In addition to pain, patients with CLBP also suffer from reduced cognitive performance, depressive symptoms and catastrophic thoughts. Central sensitization (CS) is considered a key point in pain persistence. This study examines CS and its impact on cognitive, emotional, and behavioral functioning in patients with CLBP. Methods: In this cross-sectional study, 67 patients with CLBP were classified using the Central Sensitization Inventory (CSI) into groups with (WCS, n = 32) and without central sensitization (WoCS, n = 35). Cognitive functioning was assessed using the Montreal Cognitive Assessment (MoCA), emotional functioning using the Center for Epidemiologic Studies Depression Scale (CES-D), and behavioral functioning using the Pain Catastrophizing Scale (PCS), including helplessness, rumination, and magnification domains. Normality was assessed using the Shapiro–Wilk test. Between-group comparisons were performed using Mann–Whitney U, chi-square, or Welch’s t-tests. Multivariable linear regression analyses adjusted for age and gender were conducted. Results: Compared with the WoCS group, patients with central sensitization were older (median 58 vs. 50 years, p = 0.001) and more frequently female (71.9% vs. 40.0%, p = 0.018). The WCS group showed higher PCS total scores (31.8 ± 14.2 vs. 16.0 ± 11.9), higher helplessness (14.3 ± 6.1 vs. 6.9 ± 5.5), rumination (12.7 ± 6.2 vs. 7.0 ± 4.8), and magnification scores (4.8 ± 2.4 vs. 2.1 ± 2.1), higher CES-D scores (26.3 ± 10.4 vs. 11.7 ± 7.2), and lower MoCA scores (23.6 ± 3.0 vs. 26.1 ± 2.1) (all p < 0.001). All associations remained significant after adjustment for age and gender. Conclusions: Central sensitization in CLBP is independently associated with greater pain catastrophizing across all domains, increased depressive symptoms, and reduced cognitive performance, supporting its role as a multidimensional clinical phenotype.

## Full-text entities

- **Genes:** PCS [NCBI Gene 8075]
- **Diseases:** neuropsychological impairments (MESH:D060825), injury to (MESH:D014947), emotional dysregulation (MESH:D021081), Depression (MESH:D003866), psychiatric (MESH:D001523), cognitive alterations (MESH:D003072), Pain (MESH:D010146), concentration difficulties (MESH:C567712), chronic pain (MESH:D059350), CLBP (MESH:D017116), fatigue (MESH:D005221), neurological disorders (MESH:D009461)
- **Chemicals:** CBM (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023732/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13023732/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023732/full.md

---
Source: https://tomesphere.com/paper/PMC13023732